Premium
Establishment of a human cell line (HCC‐T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection
Author(s) -
Saito Hidetsugu,
Morizane Toshio,
Watanabe Tetsu,
Kagawa Tatehiro,
Iwabuchi Naoto,
Kumagai Naoki,
Inagaki Yasutaka,
Tsuchimoto Kanji,
Tsuchiya Masaharu
Publication year - 1989
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19890901)64:5<1054::aid-cncr2820640516>3.0.co;2-x
Subject(s) - hepatocellular carcinoma , medicine , immunofluorescence , virology , population , antigen , hepatitis b virus , hepatitis , virus , cell culture , pathology , hepatitis b , doubling time , cancer research , immunology , biology , antibody , environmental health , genetics
A human hepatoma cell line, designated HCC‐T, was established. The tumor was surgically obtained from a Japanese male patient with hepatocellular carcinoma (HCC) arising in a cirrhotic liver that had supposedly developed from nonAnonB (NANB) chronic hepatitis. HCC‐T exhibited a typical morphology of epithelial cells in culture. Population doubling time was 24 hours and HCC‐T cells had characteristics of malignant cells demonstrated by the ability to grow in a soft agar medium and transplantability to nude mice. The histologic condition of the tumor transplanted to a nude mouse showed similarity to the original tumor. A chromosome analysis showed that there were ten identifiable marker chromosomes and sex chromosomes with its modal number of 64. Alpha‐fetoprotein (AFP) production was demonstrated by direct immunofluorescence study, but albumin or hepatitis B surface antigen were not detectable. The integration of hepatitis B viral DNA was not demonstrable in the genome of HCC‐T cells or the original hepatoma.